Genome-wide CRISPR/Cas9 screening reveals novel target genes, whose inactivation is able to upregulate surface expression of immunotherapy target CD20

PESCHELOVÁ, Helena, Lenka DOSTÁLOVÁ, Veronika KOZLOVÁ, Aneta LEDEREROVÁ, Václav HEJRET and Michal ŠMÍDA. Genome-wide CRISPR/Cas9 screening reveals novel target genes, whose inactivation is able to upregulate surface expression of immunotherapy target CD20. In 25th Congress of European Hematology Association, Amsterdam, Nizozemsko, in HemaSphere. 2020.

Basic information

Original name

Genome-wide CRISPR/Cas9 screening reveals novel target genes, whose inactivation is able to upregulate surface expression of immunotherapy target CD20

Authors

PESCHELOVÁ, Helena, Lenka DOSTÁLOVÁ, Veronika KOZLOVÁ, Aneta LEDEREROVÁ, Václav HEJRET and Michal ŠMÍDA

Edition

25th Congress of European Hematology Association, Amsterdam, Nizozemsko, in HemaSphere, 2020

---

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology

---

Links

LQ1601, research and development project	Name: CEITEC 2020 (Acronym: CEITEC2020) Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1395/2019, interní kód MU	Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit VII (Acronym: VýDiTeHeMa VII) Investor: Masaryk University, Category A